Europe · Financial press · Financial Times
Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn

Detailed summary
Drugmaker’s potential acquisition of Ollin Biosciences is latest in glut of deals in biotechnology sector
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.ft.com)




